Journal for Veterinary Medicine, Biotechnology and Biosafety

Volume 12, Issue 1, February 2026, Pages 39–46

ISSN 2411-3174 (print version) ISSN 2411-0388 (online version)

TOXICOKINETICS OF ZINC IN RATS AFTER A SINGLE ORAL ADMINISTRATION OF ZINC CARBONATE NANOPARTICLES

Koshevoy V. I. 1, Naumenko S. V. 1, Zhukova I. O. 1, Bespalova I. I. 2, Yefimova S. L. 2

1 State Biotechnological University, Kharkiv, Ukraine, e-mail: koshevoyvsevolod@gmail.com

2 Institute for Scintillation Materials of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine

Download PDF (print version)

Citation for print version: Koshevoy, V. I., Naumenko, S. V., Zhukova, I. O., Bespalova, I. I. and Yefimova, S. L. (2026) ‘Toxicokinetics of zinc in rats after a single oral administration of zinc carbonate nanoparticles’, Journal for Veterinary Medicine, Biotechnology and Biosafety, 12(1), pp. 39–46.

Download PDF (online version)

Citation for online version: Koshevoy, V. I., Naumenko, S. V., Zhukova, I. O., Bespalova, I. I. and Yefimova, S. L. (2026) ‘Toxicokinetics of zinc in rats after a single oral administration of zinc carbonate nanoparticles’, Journal for Veterinary Medicine, Biotechnology and Biosafety, 12(1), pp. 39–46. DOI: 10.36016/JVMBBS-2026-12-1-5.

Summary. Creating modern feed additives based on biologically active nanomaterials is an important area of research for improving mineral metabolism in animals and poultry. A significant amount of research focuses on developing zinc nanoparticles with a wide range of pharmacological effects. However, most zinc nanocomposites are toxic, even in low doses, and can accumulate in the body, leading to long-term adverse effects. To address this issue, zinc carbonate nanoparticles stabilized with polyvinylpyrrolidone were synthesized and found to be non-toxic. The study aimed to advance preclinical research on the toxicokinetics of these nanoparticles by conducting an acute toxicity experiment. To this end, 96 male Wistar rats were administered a single oral dose of a colloidal zinc carbonate nanoparticle solution at the following doses: 50 mg/kg b. w. (group I), 500 mg/kg b. w. (group II), and 5,000 mg/kg b. w. (group III), based on the absolute mass of the drug. The toxicokinetic profile of the studied nanoparticles showed typical dynamics of changes in zinc content in the organs and tissues of rats — an increase in the level of this microelement in the blood (only in experimental group III on the 1st day after administration of nanoparticles by 17.5%), liver (on the 1st day in experimental group II by 18.5% and in experimental group III by 52.1%; subsequently, changes were observed only after administration of the maximum dose of the drug — on the 3rd day by 30.7%, on the 7th and 14th days, there was a tendency to increase) and kidneys (by 25.0% in experimental group II and by 36.2% in experimental group III on the 1st day after administration of nanoparticles, on the 3rd day in experimental group II it was higher by 14.9% in experimental group III by 15.9%, on the 7th day of the experiment, the zinc content remained higher than the control values by 13.4% in experimental group II and by 17.7% in experimental group III). Regardless of the dose of administered nanoparticles, zinc did not accumulate in the heart, muscles, or skin with hair. By day 14, the zinc levels in all of the rats’ examined organs and tissues were similar to those of the control group. No significant changes in zinc content were observed in experimental group I throughout the experiment. Therefore, zinc carbonate nanoparticles are safe regarding toxicokinetic parameters and do not cause long-term accumulation

Keywords: toxicity, distribution, organs, tissues

References:

Abdelhakeem, E., Mohamed, S. A., Beherei, H. H., Moaness, M. and Hegazy, D. (2025) ‘Novel biocompatible hyaluronic acid (HA)/polyvinylpyrrolidone (PVP) composites containing silver decorated-zinc MOF nanoparticles: antimicrobial activity, drug delivery and wound healing’, AAPS PharmSciTech, 27(1), p. 5. doi: 10.1208/s12249-025-03243-z.

Abo-El-Sooud, K., Abd-El Hakim, Y. M., Hashem, M. M. M., El-Metwally, A. E., Hassan, B. A. and El-Nour, H. H. M. (2023) ‘Restorative effects of gallic acid against sub-chronic hepatic toxicity of co-exposure to zinc oxide nanoparticles and arsenic trioxide in male rats’, Heliyon, 9(6), p. e17326. doi: 10.1016/j.heliyon.2023.e17326.

Ali, A., Saeed, S., Hussain, R., Afzal, G., Siddique, A. B., Parveen, G., Hasan, M. and Caprioli, G. (2023) ‘Synthesis and characterization of silica, silver-silica, and zinc oxide-silica nanoparticles for evaluation of blood biochemistry, oxidative stress, and hepatotoxicity in albino rats’, ACS Omega, 8(23), pp. 20900–20911. doi: 10.1021/acsomega.3c01674.

Ashraf, M., Zulfiqar, F., Ijaz, U., Rauf, U., Riaz, M., Arshad, S., Jamil Khan, M. and Sahin, T. (2025) ‘Nanotechnology, nano-systems and applications of nanoparticles in novel drug delivery — a comprehensive review’, Pakistan Journal of Pharmaceutical Sciences, 38(2), pp. 669–677. Available at: https://www.pjps.pk/uploads/2025/06/1749142227.pdf.

Baek, M., Chung, H. E., Yu, J., Lee, J. A., Kim, T. H., Oh, J. M., Lee, W. J., Paek, S. M., Lee, J. K., Jeong, J., Choy, J. H. and Choi, S. J. (2012) ‘Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles’, International Journal of Nanomedicine, 7, pp. 3081–3097. doi: 10.2147/IJN.S32593.

Bautista-Pérez, R., Cano-Martínez, A., Herrera-Rodríguez, M. A., Ramos-Godinez, M. D. P., Pérez Reyes, O. L., Chirino, Y. I., Rodríguez Serrano, Z. J. and López-Marure, R. (2024) ‘Oral exposure to titanium dioxide E171 and zinc oxide nanoparticles induces multi-organ damage in rats: role of ceramide’, International Journal of Molecular Sciences, 25(11), p. 5881. doi: 10.3390/ijms25115881.

Bayat, M., Daei, S., Ziamajidi, N., Abbasalipourkabir, R. and Nourian, A. (2023) ‘The protective effects of vitamins A, C, and E on zinc oxide nanoparticles (ZnO NPs)-induced liver oxidative stress in male Wistar rats’, Drug and Chemical Toxicology, 46(2), pp. 209–218. doi: 10.1080/01480545.2021.2016809.

Cao, F., Liang, K., Tang, W. W., Ni, Q. Y., Ji, Z. Y., Zha, C. K., Wang, Y. K., Jiang, Z. X., Hou, S., Tao, L. M. and Wang, X. (2024) ‘Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis’, Journal of Controlled Release, 372, pp. 551–570. doi: 10.1016/j.jconrel.2024.06.047.

CE (The Council of Europe). (1986) European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. (European Treaty Series, No. 123). Strasbourg: The Council of Europe. Available at: https://conventions.coe.int/treaty/en/treaties/html/123.htm.

CEC (The Council of the European Communities) (2010) ‘Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes’, The Official Journal of the European Communities, L 276, pp. 33–79. Available at: http://data.europa.eu/eli/dir/2010/63/oj.

Chen, A., Feng, X., Sun, T., Zhang, Y., An, S. and Shao, L. (2016) ‘Evaluation of the effect of time on the distribution of zinc oxide nanoparticles in tissues of rats and mice: a systematic review’, IET Nanobiotechnology, 10(3), pp. 97–106. doi: 10.1049/iet-nbt.2015.0006.

Cho, W. S., Kang, B. C., Lee, J. K., Jeong, J., Che, J. H. and Seok, S. H. (2013) ‘Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration’, Particle and Fibre Toxicology, 10(1), p. 9. doi: 10.1186/1743-8977-10-9.

Choi, S.-J. and Choy, J.-H. (2014) ‘Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction’, International Journal of Nanomedicine, 9(2), pp. 261–269. doi: 10.2147/ijn.s57920.

Ćurlin, M., Barbir, R., Dabelić, S., Ljubojević, M., Goessler, W., Micek, V., Žuntar, I., Pavić, M., Božičević, L., Pavičić, I. and Vinković Vrček, I.  (2021) ‘Sex affects the response of Wistar rats to polyvinyl pyrrolidone (PVP)-coated silver nanoparticles in an oral 28 days repeated dose toxicity study’, Particle and Fibre Toxicology, 18(1), p. 38. doi: 10.1186/s12989-021-00425-y.

Czyżowska, A. and Barbasz, A. (2022) ‘A review: Zinc oxide nanoparticles — friends or enemies?’, International Journal of Environmental Health Research, 32(4), pp. 1–17. doi: 10.1080/09603123.2020.1805415.

Deore, M. S., Keerthana, S., Naqvi, S., Kumar, A. and Flora, S. J. S. (2021) ‘Alpha-lipoic acid protects co-exposure to lead and zinc oxide nanoparticles induced neuro, immuno and male reproductive toxicity in rats’, Frontiers in Pharmacology, 12, p. 626238. doi: 10.3389/fphar.2021.626238.

Ding, X. Y., Hong, C. J., Liu, Y., Gu, Z. L., Xing, K. L., Zhu, A. J., Chen, W. L., Shi, L. S., Zhang, X. N. and Zhang, Q. (2012) ‘Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS’, International Journal of Nanomedicine, 7, pp. 1723–1735. doi: 10.2147/IJN.S29696.

Do Carmo Neto, J. R., Franco, P. I. R., Braga, Y. L. L., de Oliveira, J. F., Perini, H. F., Albuquerque, L. F. D., Martins, D. B., Helmo, F. R., Andrade, A. A., Miguel, M. P., Celes, M. R. N., Rocha, T. L., Almeida Silva, A. C., Machado, J. R. and da Silva, M. V. (2024) ‘Toxicity assessment of new Ag-ZnO/AgO nanocomposites: An in vitro and in vivo approach’, Journal of Functional Biomaterials, 15(3), p. 51. doi: 10.3390/jfb15030051.

El-Saadony, M. T., Fang, G., Yan, S., Alkafaas, S. S., El Nasharty, M. A., Khedr, S. A., Hussien, A. M., Ghosh, S., Dladla, M., Elkafas, S. S., Ibrahim, E. H., Salem, H. M., Mosa, W. F., Ahmed, A. E., Mohammed, D. M., Korma, S. A., El-Tarabily, M. K., Saad, A. M., El-Tarabily, K. A. and AbuQamar, S. F. (2024) ‘Green synthesis of zinc oxide nanoparticles: Preparation, characterization, and biomedical applications — A review’, International Journal of Nanomedicine, 19, pp. 12889–12937. doi: 10.2147/IJN.S487188.

Fatima, A., Zaheer, T., Pal, K., Abbas, R. Z., Akhtar, T., Ali, S. and Mahmood, M. S. (2024) ‘Zinc oxide nanoparticles significant role in poultry and novel toxicological mechanisms’, Biological Trace Element Research, 202(1), pp. 268–290. doi: 10.1007/s12011-023-03651-x.

Fennell, T. R., Mortensen, N. P., Black, S. R., Snyder, R. W., Levine, K. E., Poitras, E., Harrington, J. M., Wingard, C. J., Holland, N. A., Pathmasiri, W. and Sumner, S. C. (2017) ‘Disposition of intravenously or orally administered silver nanoparticles in pregnant rats and the effect on the biochemical profile in urine’, Journal of Applied Toxicology, 37(5), pp. 530–544. doi: 10.1002/jat.3387.

Ferdous, Z., Beegam, S., Tariq, S., Ali, B. H. and Nemmar, A. (2018) ‘The in vitro effect of polyvinylpyrrolidone and citrate coated silver nanoparticles on erythrocytic oxidative damage and eryptosis’, Cellular Physiology and Biochemistry, 49(4), pp. 1577–1588. doi: 10.1159/000493460.

Fujihara, J. and Nishimoto, N. (2024) ‘Review of zinc oxide nanoparticles: toxicokinetics, tissue distribution for various exposure routes, toxicological effects, toxicity mechanism in mammals, and an approach for toxicity reduction’, Biological Trace Element Research, 202(1), pp. 9–23. doi: 10.1007/s12011-023-03644-w.

Fujihara, J., Tongu, M., Hashimoto, H., Yamada, T., Kimura-Kataoka, K., Yasuda, T., Fujita, Y. and Takeshita, H. (2015) ‘Distribution and toxicity evaluation of ZnO dispersion nanoparticles in single intravenously exposed mice’, The Journal of Medical Investigation, 62(1‒2), pp. 45–50. doi: 10.2152/jmi.62.45.

Hadrup, N., Vogel, U. and Jacobsen, N. R. (2025) ‘Biokinetics of inhaled silver, gold, copper oxide, and zinc oxide nanoparticles: A review’, Nanotoxicology, 19(3), pp. 259–289. doi: 10.1080/17435390.2025.2476994.

Hashim, M., Anjum, S., Mujahid, H., Alotaibi, K. S., Albattal, S. B., Ghamry, H. I. and Soliman, M. M. (2025) ‘Thymoquinone loaded zinc oxide nanoformulations synthesis, characterization and evaluation of their efficacy against carbon tetrachloride induced hepatorenal toxicity in rats’, Toxicology Research, 14(2), p. tfaf037. doi: 10.1093/toxres/tfaf037.

Iqbal, R., Qureshi, O. S., Yousaf, A. M., Raza, S. A., Sarwar, H. S., Shahnaz, G., Saleem, U. and Sohail, M. F. (2021) ‘Enhanced solubility and biopharmaceutical performance of atorvastatin and metformin via electrospun polyvinylpyrrolidone-hyaluronic acid composite nanoparticles’, European Journal of Pharmaceutical Sciences, 161, p. 105817. doi: 10.1016/j.ejps.2021.105817.

Jafary, F., Motamedi, S. and Karimi, I. (2023) ‘Veterinary nanomedicine: Pros and cons’, Veterinary Medicine and Science, 9(1), pp. 494–506. doi: 10.1002/vms3.1050.

Kausar, S., Jabeen, F., Latif, M. A. and Asad, M. (2023) ‘Characterization, dose dependent assessment of hepatorenal oxidative stress, hematological parameters and histopathological divulging of the hepatic damages induced by Zinc Oxide Nanoparticles (ZnO-NPs) in adult male Sprague dawley rats’, Saudi Journal of Biological Sciences, 30(9), p. 103745. doi: 10.1016/j.sjbs.2023.103745.

Keerthana, S. and Kumar, A. (2020) ‘Potential risks and benefits of zinc oxide nanoparticles: A systematic review’, Critical Reviews in Toxicology, 50(1), pp. 47–71. doi: 10.1080/10408444.2020.1726282.

Kermanizadeh, A., Powell, L. G., Stone, V. and Møller, P. (2018) ‘Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape’, International Journal of Nanomedicine, 13, pp. 7575–7605. doi: 10.2147/ijn.s177418.

Koshevoy, V., Naumenko, S., Orobchenko, O. and Bespalova, I. (2023) ‘Acute toxicity of zinc carbonate nanocrystals on white mice model’ [Hostra toksychnist nanokrystaliv tsynku karbonatu na modeli bilykh myshei], Scientific Messenger of Lviv National University of Veterinary Medicine and Biotechnologies named after S. Z. Gzhytskyj. Series: Veterinary Sciences [Naukovyi visnyk Lvivskoho natsionalnoho universytetu veterynarnoi medytsyny ta biotekhnolohii imeni S. Z. Gzhytskoho. Seriia: Veterynarni Nauky], 25(112), pp. 123–130. doi: 10.32718/nvlvet11220. [in Ukrainian].

Koshevoy, V. I., Naumenko, S. V., Bespalova, I. I., Radzikhovskyi, M. L. and Balym, Yu. P. (2024a) ‘Dynamics of the activity of hepato-specific enzymes and the state of protein synthesizer function of the liver in rats during chronic intake of zinc carbonate hydroxide nanoparticles’ [Dynamika aktyvnosti hepatospetsyfichnykh enzymiv ta stan proteinsyntezuvalnoi funktsii pechinky u shchuriv za khronichnoho nadkhodzhennia nanochastynok tsynku hidrokarbonatu], Veterinary Medicine [Veterynarna medytsyna], 110, pp. 188–196. doi: 10.36016/VM-2024-110-29. [in Ukrainian].

Koshevoy, V. I., Naumenko, S. V., Bespalova, I. I. and Yefimova, S. L. (2024b) ‘Biochemical parameters of nephrotoxicity of zinc hydrocarbonate nanocrystals’ [Biokhimichni parametry nefrotoksychnosti nanokrystaliv tsynku hidrokarbonatu], Scientific Messenger of Lviv National University of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences [Naukovyi visnyk Lvivskoho natsionalnoho universytetu veterynarnoi medytsyny ta biotekhnolohii. Seriia: Veterynarni nauky], 26(116), pp. 270–277. doi: 10.32718/nvlvet11639. [in Ukrainian].

Koshevoy, V., Naumenko, S., Bespalova, I. and Yefimova, S. (2025a). ‘Effect of zinc carbonate nanoparticles subchronic intake on antioxidant status of male rabbits’, Journal for Veterinary Medicine Biotechnology and Biosafety, 11(4), pp. 3‒11. doi: 10.36016/jvmbbs-2025-11-4-1.

Koshevoy, V. I., Naumenko, S. V., Bespalova, I. I. and Yefimova, S. L. (2025b) ‘Hematotoxicity of zinc carbonate nanoparticles in the Wistar rat model’, Ukrainian Journal of Veterinary and Agricultural Sciences, 8(1), pp. 21–26. doi: 10.32718/ujvas8-1.04.

Lee, J., Yu, W. J., Song, J., Sung, C., Jeong, E. J., Han, J. S., Kim, P., Jo, E., Eom, I., Kim, H. M., Kwon, J. T., Choi, K., Choi, J., Kim, H., Lee, H., Park, J., Jin, S. M. and Park, K. (2016) ‘Developmental toxicity of intravenously injected zinc oxide nanoparticles in rats’, Archives of Pharmacal Research, 39(12), pp. 1682–1692. doi: 10.1007/s12272-016-0767-z.

Li, M., Zou, P., Tyner, K. and Lee, S. (2017) ‘Physiologically based pharmacokinetic (PBPK) modeling of pharmaceutical nanoparticles’, The AAPS Journal, 19(1), pp. 26–42. doi: 10.1208/s12248-016-0010-3.

Li, W., Lu, X., Jiang, L. and Wang, X. (2024a) ‘Biosafety and pharmacokinetic characteristics of polyethylene pyrrolidone modified nano selenium in rats’, BMC Biotechnology, 24(1), p. 98. doi: 10.1186/s12896-024-00915-9.

Li, W., Lu, X., Jiang, L. and Wang, X. (2024b) ‘Radioprotective effect of polyvinylpyrrolidone modified selenium nanoparticles and its antioxidation mechanism in vitro and in vivo’, Frontiers in Bioengineering and Biotechnology, 12, p. 1392339. doi: 10.3389/fbioe.2024.1392339.

Li, Y., Li, J., Li, M., Sun, J., Shang, X. and Ma, Y. (2024a) ‘Biological mechanism of ZnO nanomaterials’, Journal of Applied Toxicology, 44(1), pp. 107–117. doi: 10.1002/jat.4522.

Li, Y., Lu, Y., Li, J., Li, M., Gou, H., Sun, X., Xu, X., Song, B., Li, Z. and Ma, Y. (2024b) ‘Screening of low-toxic zinc oxide nanomaterials and study the apoptosis mechanism of NSC-34 cells’, Biotechnology Journal, 19(2), p. e2300443. doi: 10.1002/biot.202300443.

Liang, C., Fang, J., Hu, J., Geng, X., Liu, H., Feng, Y., Wang, W., Cui, W., Yu, Z. and Jia, X. (2022) ‘Toxicokinetics of zinc oxide nanoparticles and food grade bulk-sized zinc oxide in rats after oral dosages’, NanoImpact, 25, p. 100368. doi: 10.1016/j.impact.2021.100368.

Liu, J., Feng, X., Wei, L., Chen, L., Song, B. and Shao, L. (2016) ‘The toxicology of ion-shedding zinc oxide nanoparticles’, Critical Reviews in Toxicology, 46(4), pp. 348–384. doi: 10.3109/10408444.2015.1137864.

Malik, S., Muhammad, K. and Waheed, Y. (2023) ‘Emerging applications of nanotechnology in healthcare and medicine’, Molecules, 28(18), p. 6624. doi: 10.3390/molecules28186624.

Naumenko, S., Koshevoy, V., Matsenko, O., Miroshnikova, O., Zhukova, I. and Bespalova, I. (2023) ‘Antioxidant properties and toxic risks of using metal nanoparticles on health and productivity in poultry’, Journal of World`s Poultry Research, 13(3), pp. 292–306. doi: 10.36380/jwpr.2023.32.

Paek, H. J., Lee, Y. J., Chung, H. E., Yoo, N. H., Lee, J. A., Kim, M. K., Lee, J. K., Jeong, J. and Choi, S. J. (2013) ‘Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo’, Nanoscale, 5(23), pp. 11416–11427. doi: 10.1039/c3nr02140h.

Park, E. J., Jeong, U., Yoon, C. and Kim, Y. (2017) ‘Comparison of distribution and toxicity of different types of zinc-based nanoparticles’, Environmental Toxicology, 32(4), pp. 1363–1374. doi: 10.1002/tox.22330.

Pei, X., Jiang, H., Xu, G., Li, C., Li, D. and Tang, S. (2022) ‘Lethality of zinc oxide nanoparticles surpasses conventional zinc oxide via oxidative stress, mitochondrial damage and calcium overload: A comparative hepatotoxicity study’, International Journal of Molecular Sciences, 23(12), p. 6724. doi: 10.3390/ijms23126724.

Rahman, H. S., Othman, H. H., Abdullah, R., Edin, H. A. S. and Al-Haj, N. A. (2022) ‘Beneficial and toxicological aspects of zinc oxide nanoparticles in animals’, Veterinary Medicine and Science, 8(4), pp. 1769–1779. doi: 10.1002/vms3.814.

Rehman, N., Jabeen, F., Asad, M., Nijabat, A., Ali, A., Khan, S. U., Luna-Arias, J. P., Mashwani, Z. U., Siddiqa, A., Karthikeyan, A. and Ahmad, A. (2024) ‘Exposure to zinc oxide nanoparticles induced reproductive toxicities in male Sprague Dawley rats’, Journal of Trace Elements in Medicine and Biology, 83, p. 127411. doi: 10.1016/j.jtemb.2024.127411.

Sarcinelli, M. A., Gullo, M. P., Gentile, G., Cocca, M. C., Errico, M. E., Avella, M. and Tavares, M. I. B. (2021) ‘Polyvinylpyrrolidone/ Montmorillonite/ Zinc oxide bionanosystems prepared by spray drying’, Journal of Nanoscience and Nanotechnology, 21(9), pp. 4830–4839. doi: 10.1166/jnn.2021.19284.

Shahrousvand, M., Mirmasoudi, S. S., Pourmohammadi-Bejarpasi, Z., Feizkhah, A., Mobayen, M., Hedayati, M., Sadeghi, M., Esmaelzadeh, M., Mirkatoul, F. B. and Jamshidi, S. (2023) ‘Polyacrylic acid/ polyvinylpyrrolidone hydrogel wound dressing containing zinc oxide nanoparticles promote wound healing in a rat model of excision injury’, Heliyon, 9(8), p. e19230. doi: 10.1016/j.heliyon.2023.e19230.

Simmonds, R. C. (2017) ‘Chapter 4. Bioethics and animal use in programs of research, teaching, and testing’, in Weichbrod, R. H., Thompson, G. A. and Norton, J. N. (eds.) Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd ed. Boca Raton: CRC Press, pp. 35–62. doi: 10.1201/9781315152189-4.

Van Emden, H. F. (2019) Statistics for Terrified Biologists. 2nd ed. Hoboken, NJ: John Wiley & Sons. ISBN 9781119563679.

VRU (Verkhovna Rada Ukrainy) (2006) ‘Law of Ukraine No. 3447-IV of 21.02.2006 ‘About protection of animals from cruel treatment’ [Zakon Ukrainy № 3447-IV vid 21.02.2006 ‘Pro zakhyst tvaryn vid zhorstokoho povodzhennia’], News of the Verkhovna Rada of Ukraine [Vidomosti Verkhovnoi Rady Ukrainy], 27, art. 230. Available at: https://zakon.rada.gov.ua/laws/3447-15. [in Ukrainian].

Wang, C., Lu, J., Zhou, L., Li, J., Xu, J., Li, W., Zhang, L., Zhong, X. and Wang, T. (2016) ‘Effects of long-term exposure to zinc oxide nanoparticles on development, zinc metabolism and biodistribution of minerals (Zn, Fe, Cu, Mn) in mice’, PloS One, 11(10), p. e0164434. doi: 10.1371/journal.pone.0164434.

Yang, J., Xiong, D. and Long, M. (2025) ‘Zinc oxide nanoparticles as next-generation feed additives: bridging antimicrobial efficacy, growth promotion, and sustainable strategies in animal nutrition’, Nanomaterials, 15(13), p. 1030. doi: 10.3390/nano15131030.

Yang, K., Zhu, R., Bao, H., Xu, S., Gao, Y., Xue, Y., Wang, J., Wang, X., Pan, Y., Hong, L. and Zhao, K. (2025) ‘Chitosan-based nanomaterials: Pioneering a review in veterinary medicine applications’, International Journal of Biological Macromolecules, 320(4), p. 146011. doi: 10.1016/j.ijbiomac.2025.146011.

Yue, W., Wang, X., Zhang, J., Bao, J. and Yao, M. (2024) ‘Construction of immobilized laccase system based on ZnO and degradation of mesotrione’, Toxics, 12(6), p. 434. doi: 10.3390/toxics12060434.

Yun, J. W., Yoon, J. H., Kang, B. C., Cho, N. H., Seok, S. H., Min, S. K., Min, J. H., Che, J. H. and Kim, Y. K. (2015) ‘The toxicity and distribution of iron oxide-zinc oxide core-shell nanoparticles in C57BL/6 mice after repeated subcutaneous administration’, Journal of Applied Toxicology, 35(6), pp. 593–602. doi: 10.1002/jat.3102.

Zhang, S. Q., Yu, X. F., Zhang, H. B., Peng, N., Chen, Z. X., Cheng, Q., Zhang, X. L., Cheng, S. H. and Zhang, Y. (2018) ‘Comparison of the oral absorption, distribution, excretion, and bioavailability of zinc sulfate, zinc gluconate, and zinc-enriched yeast in rats’, Molecular Nutrition & Food Research, 62(7), p. e1700981. doi: 10.1002/mnfr.201700981.